Skip to main content

Table 1 Study participants characteristics at the time of starting TB treatment

From: Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9-year longitudinal study

Features

HIV negative (N = 19,019)

HIV positive (N = 7879)

HIV status unknown (N = 387)

All patients (N = 27,285)

Sex

 Male

13,253 (70)

3930 (50)

267 (69)

17,450 (64)

 Female

5766 (30)

3949 (50)

120 (31)

9835 (36)

Age in years

 18 to 30 years

6853 (36)

1700 (22)

121 (31)

8674 (32)

 31 to 40 years

4629 (24)

2974 (38)

93 (24)

7696 (28)

 41 to 50 years

2780 (15)

2125 (27)

65 (17)

4970 (18)

 51 + years

4757 (25)

1080 (14)

108 (28)

5945 (22)

Patient type

 New cases

16,801 (88)

6821 (87)

364 (94)

23,986 (88)

 Re-treatment cases

2218 (12)

1058 (13)

23 (5.9)

3299 (12)

TB type

 Pulmonary

16,585 (87)

6732 (85)

322 (83)

23,639 (87)

 Extrapulmonary

2434 (13)

1147 (15)

65 (17)

3646 (13)

Recruitment health facility

 Public

15,429 (81)

5691 (72)

295 (76)

21,415 (78)

 Private

3183 (17)

2070 (26)

87 (22)

5340 (20)

 Prisons

407 (2.1)

118 (1.5)

5 (1.3)

530 (1.9)

DOT

 Family-based

17,369 (91)

7098 (90)

375 (97)

24,842 (91)

 Community volunteer

645 (3.4)

246 (3.1)

2 (0.5)

893 (3.3)

 Health worker

1005 (5.3)

535 (6.8)

10 (2.6)

1550 (5.7)

Nutrition status

 Undernourished

6080 (32)

2290 (29)

98 (25)

8468 (31)

 Normal BMI

9738 (51)

4170 (53)

174 (45)

14,082 (52)

 Overweight

2151 (11)

932 (12)

37 (9.6)

3120 (11)

 Not reported

1050 (5.5)

487 (6.2)

78 (20)

1615 (5.9)

Method of TB diagnosis

 Clinical signs

8356 (44)

4658 (59)

204 (53)

13,218 (48)

 Bacteriological confirmed

10,663 (56)

3221 (41)

183 (47)

14,067 (52)

Treatment regimen

 2RHZE/4RH

17,674 (93)

6875 (87)

349 (90)

24,898 (91)

 2SRHZE/1RHZE/5RHE

971 (5.1)

832 (11)

10 (2.6)

1813 (6.6)

 2RHZ/4RH

296 (1.6)

95 (1.2)

24 (6.2)

415 (1.5)

 Others

78 (0.4)

77 (1.0)

4 (1.0)

159 (0.6)

County

 Kilifi

11,256 (59)

4553 (58)

165 (43)

15,974 (59)

 Nyeri

7763 (41)

3326 (42)

222 (57)

11,311 (41)

Year of diagnosis

 2012

2408 (13)

1174 (15)

67 (17)

3649 (13)

 2013

2165 (11)

1032 (13)

52 (13)

3249 (12)

 2014

2132 (11)

1085 (14)

78 (20)

3295 (12)

 2015

2061 (11)

872 (11)

21 (5.4)

2954 (11)

 2016

1677 (8.8)

755 (9.6)

25 (6.5)

2457 (9.0)

 2017

2004 (11)

774 (9.8)

27 (7.0)

2805 (10)

 2018

2539 (13)

922 (12)

27 (7.0)

3488 (13)

 2019

2284 (12)

711 (9.0)

42 (11)

3037 (11)

 2020

1749 (9.2)

554 (7.0)

48 (12)

2351 (8.6)

  1. DOT Direct observed treatment, BMI Body Mass Index, ARVs Antiretroviral, new patients have never been treated for TB or taken anti-TB drugs for less than one month, Re-treatment cases have received one month or more of anti-TB drugs in the past and includes relapsed patients, all results are N(%)